-
-
Pharma & Human Health -
Pharma & Human Health -
Pharma & Human Health -
Finance
Editor’s Choice
Editor's Choice
Seres Therapeutics, Nestlé Health Science Announce SER-109 Co-Commercialization License Agreement
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, announced today that it has entered into an agreement with Nestlé Health Science to jointly commercialize SER-109, Seres’ investigational oral microbiome therapeutic for recurrent Clostridioides […]
Editor's Choice
Ferring and Rebiotix Present Landmark Phase 3 Data
Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today presented results from the pivotal Phase 3 PUNCH™ CD3 clinical trial, demonstrating superior efficacy and consistent safety of single-dose RBX2660 in reducing recurrence of Clostridioides difficile infection (CDI) […]
Editor's Choice
The surprising evolutionary history of our oral bacteria
Living in and on our bodies are trillions of microbial cells belonging to thousands of bacterial species – our microbiome. These microbes play key roles in human health, but little is known about their evolution. […]
In Case you Missed it:
Pharma & Human Health
Microbes turn back the clock as research discovers their potential to reverse aging in the brain
Research from APC Microbiome Ireland (APC) at University College Cork (UCC) published in the leading international scientific journal Nature Aging introduces a novel approach to reverse aspects of aging-related deterioration in the brain and cognitive function […]
Pharma & Human Health
5 Tips for Making the Most of your Microbiome Analysis
The number of published scientific papers on the microbiome has increased year after year for the past decade, and is now at an all-time high. Research is moving beyond preliminary association studies, toward more sophisticated […]
Finance
DayTwo Announces New CEO and Raises $37 Million For Expansion of Chronic Disease Solutions
DayTwo, a leader in precision nutrition with the world’s most advanced proprietary microbiome science, today announced that the company appointed David Henderson, a former founding executive member of Oscar Health, as Chief Executive Officer. The […]
Finance
AMICOGEN Inc. and Lysando AG Bring Partnership to the Next Level With Ownership Participations in Each Other’s Companies
South Korean KOSDAQ listed AMICOGEN Inc. will become the latest shareholder in Lysando AG. The transaction includes an acquisition of shares, a cash contribution to Lysando and a share package to Lysando into AMICOGEN. The […]
Finance
BiomX Inc. Announces $15 Million Registered Direct Offering
BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announced today it has entered into a definitive agreement with […]
